Problems in Bone Marrow Pathology Brussel/Bruxelles - November 2000. Introduction The role of the Bone Marrow Biopsy Dr Françoise Delacrétaz, Privat-Docent, Institute of…

1. PARP-1 Inhibitors in Oncology The Discovery and Development of CEP-9722, an Orally Active Prodrug for the Treatment of Cancer 2. Rationale for PARP-1 Inhibitors in Oncology…

1. Senesco Technologies, Inc.Changing Cancer TherapyJanuary, 2014 2. Safe Harbor StatementCertain statements included in this presentation are forward-looking statements…

Slide 1disordini linfoproliferativi (II) classificazione linfomi staging system prognosi terapia Slide 2 B-Cell Neoplasms I. Precursor B-cell neoplasm: a. Precursor B-lymphoblastic…

Slide 1Progress Against Lymphoma Slide 2 1970–1979 Slide 3 Progress Against Lymphoma 1970–1979 1974: FDA approves doxorubicin, a vital part of combination chemotherapy…

Slide 1Use of the oligonucleotide DSP30 with IL2 in the investigation of low grade B cell lymphoid neoplasms Chris Lowe, Newcastle Cytogenetic abnormalities of diagnostic…

Slide 1Egress of CD19 + CD5 + cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients by Betty…

1. Fiscal Year 2008New ICD-9-CM Codes and Introduction to MS-DRGs Barry Libman, RHIA, CCS, CCS-P President Barry Libman Inc. 2. Inpatient PPS, FY 2008 Agenda: New codesNew…

1. Indolent non Hodgkin lymphomas Dr. Rajib Bhattacharjee Junior Resident IPGMER, Kolkata 2. WHO classification 2008 3. Most common types of NHL encountered in clinical practice…

Small Bowel Adenocarcinoma Nishant Poddar, Arsh Singh, Bhawna Sharma RishitaSolanki Singh, Shahzad Raza, Hemant Singh Sindhu Madhumati Kalavar Division of Hematology/Oncology…